World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
31389
World Ranking
13066
National Ranking
6671

Samuel A. Bozzette publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Samuel A. Bozzette sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 228 publications — 5th percentile

5% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Samuel A. Bozzette D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Samuel A. Bozzette sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Samuel A. Bozzette is affiliated with the University of California, San Diego in the United States. Their research primarily focuses on medical sciences, with a particular emphasis on infectious diseases.

The scientist's work centers on several key topics:

  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Cancer Immunotherapy and Biomarkers
  • Long-Term Effects of COVID-19
  • COVID-19 and healthcare impacts
  • Sepsis Diagnosis and Treatment
  • Pneumonia and Respiratory Infections

Within medical subfields, their publications include research in:

  • Infectious Diseases
  • Oncology
  • Epidemiology
  • Neurology
  • Molecular Biology

Frequent collaborators in their research include William G. Powderly, Kevin J. Anstrom, Lisa M. LaVange, Jane A. O'Halloran, and Emily R. Ko.

Their publications have appeared in several venues, such as:

  • JAMA
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Open Forum Infectious Diseases
  • UNC Libraries
  • International Journal of Infectious Diseases

Some of the recent papers authored or co-authored by Samuel A. Bozzette include:

  • "Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia," 2023, JAMA
  • "Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19," 2022, bioRxiv (Cold Spring Harbor Laboratory)
  • "Abatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19," 2022, bioRxiv (Cold Spring Harbor Laboratory)
  • "Efficacy of infliximab, abatacept, and cenicriviroc for the treatment of adults hospitalized with COVID-19 pneumonia," 2024, International Journal of Infectious Diseases
  • "LB1531A. Administration of abatacept, reduces mortality in hospitalized patients with COVID pneumonia. Results of a randomized controlled trial.," 2022, Open Forum Infectious Diseases

Samuel A. Bozzette is a recognized member of the Association of American Physicians.

Best Publications

  • Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents

    A. S. Fauci;J. G. Bartlett;E. P. Goosby;M. D. Smith

  • Psychiatric Disorders and Drug Use Among Human Immunodeficiency Virus–Infected Adults in the United States

    Eric G. Bing;M. Audrey Burnam;Douglas Longshore;Douglas Longshore;John A. Fleishman

  • Variations in the Care of HIV-Infected Adults in the United States: Results From the HIV Cost and Services Utilization Study

    M F Shapiro;S C Morton;D F McCaffrey;J W Senterfitt

  • Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.

    Samuel A. Bozzette;Christopher F. Ake;Henry K. Tam;Henry K. Tam;Sophia W. Chang

  • A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection

    Albert W. Wu;Haya R. Rubin;William C. Mathews;John E. Ware Jr.

  • Guidelines for preventing opportunistic infections among HIV-infected persons - 2002

    Henry Masur;Jonathan E. Kaplan;King K. Holmes;Beverly Alston

  • Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens.

    Allen L. Gifford;Jill E. Bormann;Martha J. Shively;Brian C. Wright

  • The Impact of the Syncytium-Inducing Phenotype of Human Immunodeficiency Virus on Disease Progression

    Douglas D. Richman;Samuel A. Bozzette

  • A Controlled Trial of Early Adjunctive Treatment with Corticosteroids for Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome

    S A Bozzette;F R Sattler;J Chiu;A W Wu

  • The Care of HIV-Infected Adults in the United States

    S A Bozzette;S H Berry;N Duan;M R Frankel;M R Frankel

  • The prevalence of antiretroviral drug resistance in the United States.

    Douglas Richman;Sally C. Morton;Terri Wrin;Nicholas Hellmann;Nicholas Hellmann

  • Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study.

    Ron D Hays;Ron D Hays;William E Cunningham;Cathy D Sherbourne;Ira B Wilson

  • Recombinant Human Growth Hormone in Patients with HIV-Associated Wasting: A Randomized, Placebo-Controlled Trial

    Morris Schambelan;Kathleen Mulligan;Carl Grunfeld;Eric S. Daar

  • Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome

    P. Meier;J. A. Mccutchan;S. A. Bozzette;M. Clement

  • Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base

    Julia E Aledort;Nicole Lurie;Jeffrey Wasserman;Samuel A Bozzette;Samuel A Bozzette

  • Prophylaxis against Disseminated Mycobacterium avium Complex with Weekly Azithromycin, Daily Rifabutin, or Both

    Diane V. Havlir;Michael P. Dubé;Fred R. Sattler;Donald N. Forthal

  • A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection.

    S. A. Bozzette;D. M. Finkelstein;S. A. Spector;P. Frame

  • A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection

    William G. Powderly;Dianne M. Finkelstein;Judith Feinberg;Peter Frame

  • Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS

    Albert W. Wu;Ron D. Hays;S Kelly;Faye E. Malitz

  • Impact of psychiatric conditions on health-related quality of life in persons with HIV infection

    Cathy D. Sherbourne;Ron D. Hays;John Fleishman;Benedetto Vitiello

Frequent Co-Authors

Martin F. Shapiro
Martin F. Shapiro Cornell University
Steven M. Asch
Steven M. Asch Stanford University
Ron D. Hays
Ron D. Hays University of California, Los Angeles
Sally C. Morton
Sally C. Morton Arizona State University
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Stephen A. Spector
Stephen A. Spector University of California, San Diego
Ronald M. Andersen
Ronald M. Andersen University of California, Los Angeles
J. Allen McCutchan
J. Allen McCutchan University of California, San Diego
David E. Kanouse
David E. Kanouse RAND Corporation
Stephen Crystal
Stephen Crystal Rutgers, The State University of New Jersey

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers without committing to a traditional medical degree, there are numerous flexible options. Innovative online programs now offer affordable and accessible entry points for nursing and allied health professions.

Prospective registered nurses can consider the cheapest rn to bsn online programs, which enable licensed RNs to earn a bachelor’s degree at a lower cost. For career-changers or non-nurses, entry level msn programs online offer accelerated pathways into advanced nursing roles.

Those without prior nursing experience may also explore online adn programs for non nurses as a quicker route to becoming a registered nurse. Alternatively, if you are interested in administrative roles, online medical billing and coding schools that accept fafsa provide vital training for in-demand healthcare support positions.

These online degrees allow for career advancement or a fresh start in healthcare, often with flexible schedules, lower costs, and the ability to learn while working.

Best Scientists Citing Samuel A. Bozzette

Trending Scientists

Recently Published Articles